Sunshine Biopharma (SBFM) Gross Profit Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFM) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 7.62% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.71% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 12.55% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 76.85% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.80% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.95% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -35.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 37.26% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 44.16% |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | 6.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.06% |
| Dec 31, 2025 | 26.64% |
| Sep 30, 2025 | 257.93% |
| Jun 30, 2025 | 256.38% |
| Mar 31, 2025 | 251.63% |
| Dec 31, 2024 | 406.32% |
| Sep 30, 2024 | 352.82% |
| Jun 30, 2024 | 309.32% |
| Mar 31, 2024 | 378.14% |
| Dec 31, 2023 | 426.96% |
| Sep 30, 2023 | 468.89% |
| Jun 30, 2023 | 480.47% |
| Mar 31, 2023 | 532.67% |
| Dec 31, 2022 | 516.27% |
| Sep 30, 2022 | 220.65% |
| Jun 30, 2022 | 263.62% |
| Mar 31, 2022 | 774.20% |
| Mar 31, 2021 | 61.75% |